NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · IEX Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: May 1, 2024, 4:00 PM
1.140
-0.020 (-1.72%)
After-hours: May 1, 2024, 7:56 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $2.82M in the twelve months ending December 31, 2023, down -22.86% year-over-year. Revenue in the quarter ending December 31, 2023 was $977.65K, a -37.72% decrease year-over-year. In the fiscal year ending September 30, 2023, NeuroOne Medical Technologies had annual revenue of $3.41M with 60.73% growth.
Revenue (ttm)
$2.82M
Revenue Growth
-22.86%
P/S Ratio
10.68
Revenue / Employee
$175,969
Employees
16
Market Cap
30.08M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nutex Health | 247.65M |
Spectral AI | 18.06M |
DURECT | 8.55M |
Palatin Technologies | 7.10M |
Singular Genomics Systems | 2.91M |
Femasys | 1.07M |
NMTC News
- 21 days ago - NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology - GlobeNewsWire
- 22 days ago - NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes - GlobeNewsWire
- 27 days ago - NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co. - GlobeNewsWire
- 5 weeks ago - NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System - GlobeNewsWire
- 7 weeks ago - NeuroOne® to Participate in the 36th Annual Roth Conference - GlobeNewsWire
- 2 months ago - NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 - GlobeNewsWire